Business Segments BRAIN Biotech AG

Equities

Market Closed - Xetra Other stock markets 11:36:03 2025-01-24 am EST			After market 02:49:07 pm
3.260 ^EUR	+0.62%		3.150	-3.37%

Jan. 14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI
Dec. 12	BRAIN Biotech AG - Analyst/Investor Day

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (EUR)

Fiscal Period: September	2020	2021	2022	2023	2024
Inorganic Dyes and Pigments
Bioproducts	25.23M	28.3M	37.7M	42.64M	42.64M
EBITDA	2.53M	3.3M	4.9M	5.48M	5.31M
D&A	3.01M	2.73M	2.99M	3.26M	3.59M
Operating Income	-660K	948K	1.93M	1.92M	1.72M
rDNA Pharmaceuticals
Bioscience (excl. Bioincubator)	-	-	-	12.68M	11.1M
EBITDA	-	-	-	768K	-172K
D&A	-	-	-	1.4M	1.23M
Operating Income	-	-	-	-954K	-1.69M
Bio Science	13.92M	11.08M	12.71M	-	-
EBITDA	-4.54M	-5.38M	-4.9M	-	-
D&A	1.34M	1.29M	1.35M	-	-
Operating Income	-7.56M	-7.49M	-7.48M	-	-
Gene Research and Development
Bioincubator	-	-	-	944K	2.05M
EBITDA	-	-	-	-2.73M	-2.13M
Operating Income	-	-	-	-2.73M	-2.13M
Reconciliation	-86K	-159K	-118K	-39K	-286K
EBITDA	-5K	-7K	-101K	3K	-91K
Operating Income	-5K	-7K	-101K	3K	-91K
EBITDA	-	-	-	-3.12M	-3.34M
Operating Income	-	-	-	-3.72M	-6.66M

Geographical breakdown of sales (EUR)

Fiscal Period: September	2020	2021	2022	2023	2024
Other Abroad	12.96M	10.7M	13.58M	16.47M	16.58M
USA	6.88M	8.86M	14.02M	15.31M	13.51M
Total Assets	838K	1.97M	1.93M	1.66M	1.38M
Netherlands	-	4.98M	6.54M	10.38M	11.28M
Total Assets	-	-	5.29M	4.89M	4.54M
Germany	8.9M	7.07M	7.93M	5.66M	6.65M
Total Assets	15.87M	14.51M	13.1M	12.21M	11.07M
United Kingdom	4.53M	3.7M	3.64M	4.77M	3.68M
Total Assets	21.03M	21.34M	25.18M	25.17M	25.05M
France	4.95M	3.08M	3.8M	2.74M	2.92M
Total Assets	-	-	-	-	-